In conclusion, apoA2-i may enhance the sensitivity of detecting CA19-9-negative stage 0 and IA PC, and complementary measurements with CA19-9 could be beneficial for diagnosing early-stage PC. This evidence concerns the gene APOA2 and pachyonychia congenita.